IGF2BP3 and urinary bladder cancer: When we explored the sensitivity of chemotherapy, flow cytometry demonstrated that knockdown of CDK6 could significantly increase the apoptosis rate of bladder cancer cells reduced by IGF2BP3 (Figure 7E and Figure S6E).